CDK5 and Alzheimer disease: In particular, atypical cyclin-dependent kinase 5 (CDK5) [224] plays a major role in regulating the size of the synaptic vesicle pool by targeting synaptic vesicle endocytosis [225], and consistently, CDK5 is significantly higher in postmortem AD brains [226, 227].